Publications by authors named "Emma Grabarnik"

Claim this Profile
G
Galectin-3 is a Nanotherapeutic Target in Graft-versus-Host Disease Mediated Kidney Injury.
Magdalini Panagiotakopoulou, Ashley N Sullivan, Kimon V Argyropoulos, Anastasia I Kousa, Jorge Nunez, Emma Grabarnik

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community.
Rachael M Crist, Yechezkel Barenholz, Ahuva Cern, Kate N Clark, Pieter R Cullis, Emma Grabarnik

Wiley Interdiscip Rev Nanomed Nanobiotechnol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study.
Edward Cedrone, Abbas Ishaq, Emma Grabarnik, Elijah Edmondson, Sarah Skoczen

Nanomedicine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoreporter Identifies Lysosomal Storage Disease Lipid Accumulation Intracranially.
Merav Antman-Passig, Zvi Yaari, Dana Goerzen, Rooshi Parikh, Savannah Chatman, Emma Grabarnik

Nano Lett· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis